2-(1-nitrosopyrrolidin-3-yl)-2,2-diphenylacetamide
Also known as: Darifenacin Nitrosamine Impurities or nitrosamine impurities of Darifenacin| Product Name | 2-(1-nitrosopyrrolidin-3-yl)-2,2-diphenylacetamide |
|---|---|
| Alternate Names | Darifenacin Impurities, Impurities of Darifenacin |
| CAT No. | CS-O-46481 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | Enquire |
| Mol. Wt. | 309.37 g/mol |
| Mol. For. | C18H19N3O2 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Darifenacin |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
2-(1-nitrosopyrrolidin-3-yl)-2,2-diphenylacetamide is a chemical compound that belongs to the class of acetamide derivatives. The chemical formula for this compound is C19H20N2O2, and its molecular weight is 308.38 g/mol. It is a yellowish-brown solid with a melting point of around 180-182°C.
This compound has been used in various studies as a potential anti-cancer agent and has also been studied for its effects on the central nervous system. It has been shown to inhibit the growth of cancer cells in vitro and in vivo, and has been suggested as a potential candidate for cancer therapy.
In terms of its chemical properties, 2-(1-nitrosopyrrolidin-3-yl)-2,2-diphenylacetamide is a nitrosamine derivative. Nitrosamines are a class of compounds that have been shown to be carcinogenic in animals and humans. However, the specific mechanism of action of this compound is not fully understood.
Overall, 2-(1-nitrosopyrrolidin-3-yl)-2,2-diphenylacetamide is a promising compound for further research into its potential as a therapeutic agent for cancer and other diseases. However, its potential toxicity and carcinogenicity should be carefully considered before any clinical application.
Get an Instant Quote
Related Compounds
Darifenacin 7-Bromoethyl Impurity | Darifenacin Bromo Impurity | Darifenacin Dimer-1 Impurity | Darifenacin Impurity 6 | Darifenacin 3-Hydroxy Impurity | Darifenacin R-Isomer (HCl) | Darifenacin acid | Darifenacin Vinyl Impurity | Darifenacin nitroso impurity | Darifenacin Impurity 11 | Darifenacin Open chain | Darifenacin 7-Bromo Analog | Darifenacin Nitrile Impurity (HCl) | Darifenacin Pyrrolidinium Dimer acetonitrile Impurity | Darifenacin Pyrrolidin Carboxylic Acid Impurity | Darifenacin Dehydro Impurity | Darifenacin Cyclic Amide-Impurity E | Darifenacin Dimer-2 Impurity | Darifenacin Carboxylic Acid Impurity | Darifenacin Impurity 10 (Tartarate salt) | Darifenacin Pyrrolidinium Dimer Impurity | Darifenacin Cyano Impurity | Darifenacin Impurity C | Darifenacin Pyrrolidine Impurity Racemate | Darifenacin 4-Hydroxy Impurity | Darifenacin Nitrile Impurity | Darifenacin 4-Hydroxy Impurity | Darifenacin Oxidized Impurity |